Exercise Performance on Ambient Air vs. Low-Flow Liquid Oxygen Therapy in Pulmonary Vascular Disease (PVD)

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
The investigators aim to study the effect of liquid oxygen therapy (4l/min, nasal) )in Swiss residents with pulmonary vascular diseases (PVD) defined as pulmonary arterial hypertension (PAH) or chronic thromboembolic pulmonary hypertension (CTEPH).
Epistemonikos ID: 698292b037f7dee7ee2177bfde8fdb2adfe29309
First added on: Aug 20, 2026